Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Preston

Showing results (41-50 of 273) with videos related to

Pageof 28
Sort By:
Journal of Clinical Pathology|June 1, 1972
Fibrin in the kidney in myelomatosisA M Ward, F E Preston
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 12, 2000
Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assayS Kitchen, J Theaker, F E Preston
British Journal of Haematology|June 1, 1994
Increased soluble IL-2 receptor levels in HCV-infected haemophiliacs: a possible indicator of liver disease severityM Makris, F E Preston, S Ralph
Thrombosis and Haemostasis|March 1, 1996
Warfarin induced skin necrosis associated with activated protein C resistanceM Makris, G Bardhan, F E Preston
British Journal of Haematology|June 1, 1984
Platelet and vascular arachidonic acid metabolites: can they help detect a tendency towards thrombosis?C Patrono, F E Preston, J Vermylen
Clinical and Laboratory Haematology|January 1, 1986
Orbital plasmacytoma in established myeloma--a report of two casesC Carter, M Greaves, F E Preston
Bailliere'S Clinical Haematology|October 1, 1989
Protein C and protein SG Dolan, J Ball, F E Preston
European Journal of Haematology|September 1, 1987
Potential value of vintristine-adriamycin-dexamethasone combination chemotherapy (VAD) in refractory and rapidly progressive myelomaR Collin, M Greaves, F E Preston
Thrombosis Research|September 1, 1982
A study of the stimulation of human venous prostacyclin synthesis by dipyridamoleC A Jackson, M Greaves, F E Preston
Lancet (London, England)|October 13, 1979
Effect of glucose on platelet thromboxane biosynthesisL Best, P B Jones, F E Preston
Pageof 28

Showing results (41-50 of 273) with videos related to

Sort By:
Pageof 28
Journal of Clinical Pathology|June 1, 1972
Fibrin in the kidney in myelomatosisA M Ward, F E Preston
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 12, 2000
Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assayS Kitchen, J Theaker, F E Preston
British Journal of Haematology|June 1, 1994
Increased soluble IL-2 receptor levels in HCV-infected haemophiliacs: a possible indicator of liver disease severityM Makris, F E Preston, S Ralph
Thrombosis and Haemostasis|March 1, 1996
Warfarin induced skin necrosis associated with activated protein C resistanceM Makris, G Bardhan, F E Preston
British Journal of Haematology|June 1, 1984
Platelet and vascular arachidonic acid metabolites: can they help detect a tendency towards thrombosis?C Patrono, F E Preston, J Vermylen
Clinical and Laboratory Haematology|January 1, 1986
Orbital plasmacytoma in established myeloma--a report of two casesC Carter, M Greaves, F E Preston
Bailliere'S Clinical Haematology|October 1, 1989
Protein C and protein SG Dolan, J Ball, F E Preston
European Journal of Haematology|September 1, 1987
Potential value of vintristine-adriamycin-dexamethasone combination chemotherapy (VAD) in refractory and rapidly progressive myelomaR Collin, M Greaves, F E Preston
Thrombosis Research|September 1, 1982
A study of the stimulation of human venous prostacyclin synthesis by dipyridamoleC A Jackson, M Greaves, F E Preston
Lancet (London, England)|October 13, 1979
Effect of glucose on platelet thromboxane biosynthesisL Best, P B Jones, F E Preston
Pageof 28